The NIH will fund up to $300,000 to projects that support testing new therapeutic uses for experimental drugs across a broad range of human diseases. This innovative program allows investigators to propose new therapeutic uses for Assets from pharmaceutical company partners. Strong applications will include scientific evidence that modulation of an Assets target should have a positive impact on the disease/condition. Submit a pre-application first.

Learn more and apply here.

Source: NIH